In a retrospective study, the results after resection of carcinoma of the g
astric cardia in the era without neoadjuvant therapy or extended lymph node
dissection were evaluated. All 184 patients who underwent resection betwee
n January 1983 and December 1993 were included. Recurrence of disease, surv
ival and prognostic factors were determined. The overall cumulative 5-year
recurrence rate was 71% and the survival rate 23%. Multivariate analysis id
entified locoregional lymph node and distant metastases as the crucial prog
nosticators of recurrence of disease and survival. These results were simil
ar to those from a previous study concerning our patients operated during t
he years 1983-88. The prognosis of a resected cardiacarcinoma has remained
unchanged in our hands over the past 10 years. These results stress the imp
ortance of exploring new ways, such as the use of new diagnostic tools, to
optimize preoperative patient selection and more aggressive treatment regim
ens to improve final outcome.